Thermo Fisher Scientific (TMO) filed a registration statement Monday with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings.
The filing covers debt securities, common stock, preferred stock, depositary shares, purchase contracts, units,
warrants, and guarantees, and includes the potential offering of debt securities by Thermo Fisher Scientific B.V.
Net proceeds will be used for general corporate purposes, which may include acquisitions, debt repayment and refinancing, working capital and capital expenditures or the repurchase of shares, the company said.
TMO shares were 1.6% higher in recent trading.
Price: 541.16, Change: +8.61, Percent Change: +1.62
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。